CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 91,646	$ 81,808
Restricted cash	1,000	1,549
Patient accounts receivable	278,216	255,145
Prepaid expenses	11,979	10,217
Other current assets	8,124	13,265
Total current assets	390,965	361,984
Property and equipment, net of accumulated depreciation of $98,552 and $95,024	20,986	23,719
Operating lease right of use assets	95,034	93,440
Goodwill	936,772	932,685
Intangible assets, net of accumulated amortization of $15,842 and $22,973	66,432	74,183
Deferred income taxes	25,271	47,987
Other assets	64,103	33,200
Total assets	1,599,563	1,567,198
Current liabilities:
Accounts payable	36,668	42,674
Payroll and employee benefits	147,017	146,929
Accrued expenses	166,157	166,192
Provider relief fund advance	58,328	60,000
Current portion of long-term obligations	10,160	10,496
Current portion of operating lease liabilities	30,893	30,046
Total current liabilities	449,223	456,337
Long-term obligations, less current portion	179,415	204,511
Operating lease liabilities, less current portion	63,152	61,987
Other long-term obligations	31,886	33,622
Total liabilities	723,676	756,457
Commitments and Contingencies—Note 6
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,553,355 and 37,470,212 shares issued; and 32,576,829 and 32,814,278 shares outstanding	38	38
Additional paid-in capital	714,334	698,287
Treasury stock, at cost 4,976,526 and 4,655,934 shares of common stock	(400,110)	(319,092)
Retained earnings	560,010	429,991
Total Amedisys, Inc. stockholders’ equity	874,272	809,224
Noncontrolling interests	1,615	1,517
Total equity	875,887	810,741
Total liabilities and equity	$ 1,599,563	$ 1,567,198